Release Date: 29/11/12 17:37 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 89.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%